Streptococcus mitis

From WikiMD's Medical Encyclopedia

Revision as of 13:19, 18 March 2025 by Prab (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Streptococcus mitis is a species of Gram-positive bacteria that belongs to the genus Streptococcus. It is a member of the viridans group streptococci, a group of catalase-negative, gram-positive cocci characterized by their resistance to optochin and their ability to produce alpha-hemolysis on blood agar.

Characteristics[edit]

Streptococcus mitis is a non-motile, non-spore-forming, facultatively anaerobic bacteria that is usually found in pairs or chains. It is a normal inhabitant of the human oral cavity and upper respiratory tract, but can also be found in the gastrointestinal tract and female genital tract.

Pathogenesis[edit]

While Streptococcus mitis is generally considered a commensal organism, it can become pathogenic under certain conditions, particularly in immunocompromised individuals. It has been associated with a variety of infections, including bacteremia, endocarditis, meningitis, and pneumonia.

Treatment[edit]

Treatment of Streptococcus mitis infections typically involves the use of antibiotics. However, resistance to certain antibiotics, including penicillin, has been reported. Therefore, susceptibility testing is often necessary to determine the most effective treatment.

Research[edit]

Research on Streptococcus mitis has contributed to our understanding of bacterial pathogenesis and antibiotic resistance. It has also been used as a model organism in studies of oral streptococci and their interactions with the human host.

See also[edit]

Stub icon
   This article is a bacteria-related stub. You can help WikiMD by expanding it!
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.